Electrophysiology Solutions

Nventric develops advanced electrophysiology technologies engineered to improve the diagnosis and treatment of cardiac arrhythmias. Our Pulse Field Ablation (PFA) and High-Density Mapping Catheters (HDMC) combine precision engineering with innovative technology to support accurate cardiac mapping, targeted tissue ablation, and improved procedural outcomes.

Conditions We Help Treat

Cardiac arrhythmias occur when the electrical impulses responsible for coordinating the heartbeat become disrupted.
These abnormalities may cause the heart to beat too rapidly, too slowly, or irregularly, potentially leading to stroke,
heart failure, syncope, or sudden cardiac death if left untreated.

Atrial Fibrillation (AF)

The most common sustained cardiac arrhythmia, characterized by rapid and disorganized atrial electrical activity that significantly increases the risk of thromboembolic stroke and heart failure.

Atrial Flutter

A macro-reentrant atrial tachyarrhythmia characterized by organized but abnormally rapid atrial activation that may coexist with atrial fibrillation.

Ventricular Tachycardia (VT)

A potentially life-threatening ventricular arrhythmia originating from abnormal electrical circuits within the ventricles, often requiring immediate intervention.

Premature Ventricular Contractions (PVCs)

Premature ventricular depolarizations that may occur sporadically or indicate underlying structural or electrical cardiac disease requiring electrophysiological evaluation.

Electrophysiology Products

Pulse Field Ablation (PFA) CatheterAGILARON ®

The Pulse Field Ablation Catheter utilizes irreversible electroporation (IRE) to selectively ablate myocardial tissue responsible for abnormal electrical conduction while minimizing collateral injury to surrounding structures. Unlike conventional radiofrequency or cryoablation techniques, pulsed field energy preserves adjacent tissues such as the esophagus, pulmonary veins, and phrenic nerve, supporting a safer and more efficient ablation strategy.

In Development

High-Density Mapping Catheter (HDMC)

The High-Density Mapping Catheter is engineered to acquire high-resolution intracardiac electrical signals that enable precise electroanatomical mapping of complex arrhythmogenic substrates. Its multi-electrode architecture captures detailed activation patterns, allowing clinicians to accurately localize abnormal conduction pathways and optimize treatment planning during electrophysiology procedures.

In Development

Why Our Electrophysiology Solutions Matter

Electrophysiology procedures continue to evolve toward greater precision, procedural efficiency, and patient safety. Nventric's catheter technologies are designed to support these advancements by combining diagnostic accuracy with innovative therapeutic capabilities.

Contact Us

Precision Tissue Ablation
Selective energy delivery enables accurate lesion formation while minimizing injury to surrounding cardiac structures.

Comprehensive Cardiac Mapping
High-density signal acquisition supports accurate identification of arrhythmogenic substrates and complex conduction pathways.

Improved Procedural Efficiency
Integrated mapping and therapeutic capabilities reduce catheter exchanges and simplify procedural workflow.

Enhanced Clinical Outcomes
Improved procedural precision contributes to safer interventions and more effective long-term arrhythmia management.

Engineering the Future of
Cardiac Rhythm Management

Nventric continues to invest in next-generation electrophysiology technologies through advanced catheter engineering, clinical collaboration, and continuous research and development. Our commitment to innovation enables physicians to perform increasingly sophisticated mapping and ablation procedures while improving procedural reproducibility, safety, and overall patient care.

Partner with Nventric to Advance Cardiac Electrophysiology

Whether you're evaluating advanced electrophysiology technologies or seeking an experienced OEM and ODM development partner, Nventric provides the engineering expertise, manufacturing capabilities, and regulatory support needed to bring innovative cardiac solutions to market.

Contact Us